Stay updated on TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record is now available with study details, eligibility criteria, locations, and outcome measures. It states that the study was terminated after enrolling 20 participants and is no longer recruiting.
    Difference
    63%
    Check dated 2026-11-11T16:48:23.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.” The clinical trial record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-21T14:33:56.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the page remained a 403 error.
    Difference
    0.2%
    Check dated 2026-10-14T16:05:45.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 error, with the footer revision updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T15:46:40.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The study page currently shows a 403 Forbidden error, indicating access is blocked for this URL rather than an update to the study's details. The site chrome remains, but the content is not retrievable.
    Difference
    0.5%
    Check dated 2026-09-30T16:23:27.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Summary
    The study page now renders as a 403 Forbidden error page, showing the site header and footer but no study content, replacing the usual study details and related information.
    Difference
    18%
    Check dated 2026-09-23T19:38:29.000Z thumbnail image

Stay in the know with updates to TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.